Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Boston Scientific's Taxus Liberte Long Stent receives CE Mark

Boston Scientific : 24 May, 2007  (New Product)
TheTaxus Liberte Long paclitaxel-eluting coronary stent system from Boston Scientific has received the CE Mark.

allowing doctors to treat longer coronary artery lesions with a single stent.
Taxus Liberte Long is the longest available drug-eluting Stent and is designed to enable doctors to treat longer coronary artery lesions with a single stent.

Taxus Liberte Long is a specialty Stent designed for more efficient stenting of long lesions (more than 32mm).

Until now, patients with longer coronary lesions have required two or more overlapping stents to cover the lesion, increasing procedure time and cost.

In the ARRIVE 1 and 2 registries (n=10,376 lesions), 10 percent of lesions required overlapping stents.

The Taxus Liberte Long Stent allows doctors to reduce the number of stents that they use, thereby simplifying the procedure.

'Long lesions can now be treated with one Taxus Liberte Stent instead of two', said Jeff Goodman, president of Boston Scientific International.

'The range of Taxus Liberte Stent sizes now available addresses the complexity of coronary artery disease and allows clinicians to choose the best Stent for each patient'.

The Taxus Liberte Long Stent combines a 38mm length with four diameters (2.75, 3.0, 3.5, and 4.0mm) and offers the flexibility and conformability of the Taxus Liberte Stent for the management of long lesions in a range of artery sizes.

The Taxus Liberte Long Stent is CE Marked for all of the same indications as the Taxus Liberte Stent system and can be used to treat de novo lesions as well as restenotic lesions, total occlusions, and acute myocardial infarction.

The Taxus Liberte Stent system is now CE marked and available outside the USA in 58 sizes in diameters from 2.25mm to 5.0mm and lengths from 8mm to 38mm.

The Taxus Liberte Stent is currently the market leading drug-eluting coronary Stent system outside the USA and the first drug-eluting Stent to incorporate a next-generation Stent platform.

The Liberte Stent features the Veriflex Stent design, a flexible cell geometry with thin struts and uniform strut distribution.

This new platform has been designed to offer improved deliverability and conformability in challenging anatomy.

The Taxus Liberte Stent and the Taxus Liberte Long Stent are not available for sale in the USA.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo